DR. KELLY E. MEEK, M.D.

Plain English
This study looked at changes in corneal thickness after a specific eye surgery called Descemet membrane endothelial keratoplasty (DMEK). Researchers found that older patients (average age 74.5 years) who had a final corneal thickness of less than 500 micrometers experienced a greater reduction in thickness by 25.5%, compared to 16.4% in those with thicker corneas. This is important because it highlights how age and certain pre-existing conditions can impact recovery after eye surgery, which can help doctors better manage patient expectations and treatment. Who this helps: This helps patients undergoing DMEK surgery and their doctors.

Plain English
This study examined the effects of a new midwifery service called MAPS on expectant mothers and their babies, comparing it to traditional care. It found that women who used the MAPS service had fewer inductions of labor (38% less), were more likely to give birth vaginally (53% more), and chose to use less formula instead of breast milk (39% less), all while reporting a high satisfaction score of nearly 5 out of 5. This matters because it shows that continuous midwifery care can lead to better experiences and outcomes for mothers and babies. Who this helps: Patients receiving maternity care.

Plain English
The study focused on how a specific protein, Lig4, is involved in repairing damaged DNA in mice. Researchers created mice with an inactive form of Lig4 and found that, while these mice were born alive, they faced growth issues and problems with immune cell development. When they also looked at mice missing another protein called Lig3, they discovered that embryos with both Lig4 and Lig3 mutations did not survive, which shows that Lig3 is essential for the DNA repair process when Lig4 is present, even if it doesn’t work properly. Who this helps: This information benefits researchers and doctors who are studying DNA repair and its implications for genetic disorders and treatments.

Plain English
This study explored how young adults with bipolar disorder respond to alcohol and placebos compared to healthy young adults. Researchers found that those with bipolar disorder reported feeling more intoxicated after consuming a placebo (a non-alcoholic drink) than healthy participants, and they showed different brain activity patterns. Notably, increased brain connectivity in a specific area (the Nucleus Accumbens) was linked to greater alcohol use and problems in these individuals over time. Who this helps: This research benefits patients with bipolar disorder by providing insights into their alcohol-related behaviors and expectations.

Plain English
This study explored how a specific enzyme called Artemis affects the effectiveness of cancer drugs known as Topoisomerase 2 (Top2) poisons. Researchers found that blocking a protein that activates Artemis made B cells more sensitive to these drugs, leading to more DNA damage in the cells. Specifically, cells with less Artemis showed a much higher buildup of DNA damage, which points to Artemis playing a bigger role in cancer treatment than previously understood. This is important because it indicates that targeting Artemis could improve the effectiveness of existing cancer therapies and potentially lead to better outcomes for patients. Who this helps: Patients with aggressive cancers.

Plain English
This study looks at a rare condition called methemoglobinemia, which can lead to low oxygen levels in the blood. A 32-year-old woman with several health issues developed serious low oxygen levels after a heart test where benzocaine was used as a numbing agent. Her methemoglobin level was found to be very high at 31.8%. She was quickly treated with a medication that improved her condition and allowed her to breathe normally again. This is important because it highlights the need for doctors to be aware of silent low oxygen levels after certain procedures, so they can act fast to prevent complications. Who this helps: This helps patients undergoing heart tests and healthcare providers involved in their care.

Plain English
This study looks at a rare type of lung tumor called pulmonary perivascular epithelioid cell tumor (PEComa) in a 62-year-old man who had the tumor spread to his lungs, causing difficulty breathing. Despite treatment with a medication called sirolimus, the tumor grew quickly, leading to the patient needing a bronchial stent to help ease his symptoms. This case shows how challenging it can be to diagnose and manage these tumors, as they can behave unpredictably and require careful, personalized treatment plans. Who this helps: This research benefits patients with rare lung tumors, their doctors, and healthcare teams involved in their treatment.

Plain English
This study looked at how certain genetic elements called Alu sequences affect the process of making proteins from genes. Researchers found that when a protein called Ku70, which helps manage these elements, is removed, it leads to incorrect processing of mRNA, causing problems in essential cellular functions and ultimately cell death. Specifically, when Ku70 was absent, the misprocessing of RNA affected crucial processes about 70% of the time, highlighting the importance of Ku70 in maintaining healthy cell function in primates. Who this helps: This benefits scientists and researchers studying genetic stability and diseases linked to RNA processing issues.

Plain English
This study looked at how recent stress affects brain responses in young adults with bipolar disorder, particularly focusing on those who have attempted suicide compared to those who haven't. The researchers found that people with a history of suicide attempts showed increased brain activity in areas linked to stress response when they were stressed, while this pattern was not seen in those without such a history. Additionally, using cannabis and nicotine was linked to even greater brain reactivity to stress in those with bipolar disorder. Who this helps: This research benefits patients with bipolar disorder, especially those at risk for suicidal thoughts and behaviors.

Plain English
This study focused on understanding how a crucial DNA repair process, called non-homologous end joining (NHEJ), works when DNA is wrapped around proteins known as nucleosomes. The researchers used advanced imaging techniques to show that a protein complex called Ku70/80 attaches to broken DNA ends and reshapes them to aid in repair. They found that this process relies on the Ku70/80 proteins making specific contacts with the DNA, which is essential for effective repair and has implications for improving cancer treatments, with their findings showing that certain conditions stabilize the repair process. Who this helps: This helps patients by providing insights that can lead to better cancer therapies.

Plain English
This study examined how HIV prevention medication called PrEP has been discussed in South African newspapers from 2012 to 2021. It found that while 52% of the articles were positive about PrEP, 11% were negative, with concerns about cost and adherence being common in unfavorable articles. Over time, the negativity in coverage lessened, which is important as it reflects growing acceptance as PrEP becomes more widely available. Who this helps: This information benefits patients at risk of HIV, especially key populations like adolescents and female sex workers.

Plain English
This study focused on how cells repair breaks in their DNA using a process called non-homologous end joining (NHEJ). Researchers discovered that NHEJ involves several stages, where the DNA breaks first come together before being joined, and they determined that this process occurs step by step in living cells. They found that the connection of DNA ends happens more effectively than previously thought, which is crucial for maintaining genetic stability. Who this helps: This helps patients by improving our understanding of DNA repair mechanisms, which may lead to better cancer treatments.

Plain English
This study looked at how a key protein, DNA-PK, helps fix the most harmful type of DNA damage, called double strand breaks (DSBs). Researchers found that DNA-PK works in several steps, first recognizing the broken DNA ends and then bringing them together for repair, but surprisingly identified two different forms of DNA-PK that play roles in this process. Understanding how DNA-PK fixes DSBs is important because it helps inform treatments for diseases caused by DNA damage, like cancer. Who this helps: This helps patients, especially those with cancer or genetic disorders related to DNA damage.

Plain English
This study looked at a protein called DNA-PK that helps fix broken DNA in higher primates, including humans. Researchers found that DNA-PK levels were 10-50 times higher in these primates compared to other mammals, while levels in prosimians (like lemurs) were much lower, similar to those found in non-primate species. This finding is important because it suggests that high levels of DNA-PK may help prevent harmful DNA rearrangements that can lead to diseases in primates. Who this helps: This research benefits patients and doctors by providing insights into the mechanisms of DNA repair that could impact treatments for genetic disorders and cancers.

Plain English
This study explored how a major DNA repair process called non-homologous end joining (NHEJ) works in live cells. Researchers used advanced imaging techniques to observe the steps involved in this repair process, finding that it involves several stages and key changes in the proteins that help fix DNA breaks. They discovered that NHEJ has a specific repair capacity, which is important for maintaining healthy cells and preventing diseases like cancer. Who this helps: This research benefits patients, especially those with conditions related to DNA damage and repair.

Plain English
This study looked at how cells repair DNA breaks, which is crucial for maintaining genetic stability. Researchers found that there are two different complexes in the repair process that each handle different tasks: one helps prepare the DNA ends for joining together, and the other processes the DNA ends in a different way. Both complexes keep the DNA ends about the same distance apart (around 115 nanometers), which is significant for effective repair. Who this helps: This helps patients with conditions related to DNA repair disorders.

Plain English
This study examined how a protein called PAXX interacts with the DNA repair process in human cells, specifically looking at its role alongside another protein, XLF, in fixing breaks in DNA. Researchers found that PAXX and XLF can work together, acting like bridges to help repair DNA more effectively, which enhances the efficiency of a critical repair mechanism known as nonhomologous end joining. The findings show that having both proteins available leads to better DNA repair, an important process for maintaining healthy cells. Who this helps: This benefits patients with DNA repair disorders or those undergoing treatments that affect DNA, like cancer patients.

Plain English
This study focused on how our cells repair critical DNA damage, specifically double-strand breaks, which can lead to serious health issues like cancer. Researchers discovered the detailed structure of a complex called DNA-PK, which works together with other proteins to fix this damage. They found that DNA-PK can form a special structure with three components, indicating it plays an important role in the repair process. This discovery matters because it improves our understanding of how cells fix their DNA, potentially leading to better treatments for DNA damage-related diseases. Who this helps: This helps patients with cancer or genetic disorders related to DNA repair.

Plain English
This study looked at responses from 1,569 dairy farms in Northern Ireland that joined a program to control Johne's disease, a serious illness in cattle. The findings showed that only 21.4% of these herds had tested for the disease, with 13.7% confirming they had cases and 31.5% suspecting they had it. Key risk factors for high rates of the disease included mixing animals from different farms and not properly managing sick animals, pointing to the need for better farm management practices. Who this helps: This benefits dairy farmers by identifying practices that can reduce disease risk and improve herd health.

Plain English
This study explored how the DNA-dependent protein kinase (DNA-PK) becomes activated when it connects to DNA ends. Researchers discovered that this activation can occur in two specific ways, depending on the structure of the DNA: one method allows the kinase to fully engage and function, while the other method only leads to partial activation. This is significant because it helps clarify the mechanisms behind DNA repair, which is crucial for maintaining genetic stability and preventing diseases like cancer. Who this helps: This helps patients with cancer or genetic disorders that affect DNA repair.

Plain English
This study looked at how a protein called DNA-PK changes its role during the repair of broken DNA. Initially, DNA-PK protects these DNA ends, but after a specific chemical change (autophosphorylation), it shifts to help process the ends for repair. Researchers found that this switch involves changes in DNA-PK's shape and function, specifically through modifications to four key areas that allow another protein, Artemis, to take action on the DNA, which is crucial for proper DNA repair. Who this helps: This research benefits scientists and medical professionals working on DNA repair mechanisms, impacting cancer treatment and genetic disorders.

Plain English
This study looked at a protein called DNA ligase IV and its role in repairing DNA damage, specifically when breaks occur in the DNA strands. The researchers found that even when this protein is inactive, it still contributes significantly to DNA repair in living cells. For instance, cells without active ligase IV showed more DNA repair through a method called alternative end-joining, but many repairs happened without the use of micro-homologous sequences, making them different from typical repairs seen in other processes. Who this helps: This research benefits patients undergoing radiation therapy or treatments that can cause DNA damage, as it improves our understanding of DNA repair mechanisms.

Plain English
This study looked at a specific genetic mutation in Bernese Mountain Dogs (BMDs) that is linked to a high risk of cancer, particularly a rare type called histiocytic sarcoma (HS). Researchers found a mutation in the FANCG gene that affects how these dogs repair their DNA, making their cells sensitive to a cancer treatment drug called cisplatin. However, this mutation alone does not cause HS, and dogs with this mutation do not show signs of related health issues, indicating they have some resistance to these problems. Who this helps: This research benefits dog owners, veterinarians, and breeders by providing insights into genetic risks in Bernese Mountain Dogs.

Plain English
This study looked at why some parents are hesitant to vaccinate their children against the HPV virus, which can cause certain cancers. Researchers interviewed 22 parents who were unsure about the vaccine and found that many felt they lacked confidence in their decision-making, wanted more information, and were unhappy with their past conversations with doctors. Improving the way information is shared, especially by pediatricians, could help these parents feel more informed and motivated to vaccinate their children. Who this helps: Parents of children aged 10-17 who are hesitant about the HPV vaccine.

Plain English
This study looked at a protein called DNA-PKcs, which is important for repairing DNA and defending against diseases. Researchers found that DNA-PKcs is not just found in vertebrates, as previously thought, but is also present in a variety of other organisms like invertebrates, fungi, and plants. They discovered specific patterns in the DNA-PKcs structure that are preserved across many species and found that strong activity of this protein in tumors can reduce patient survival, while mutations in DNA-PKcs can lead to serious health issues like immune system problems. Who this helps: This research helps patients with cancer and genetic disorders.

Plain English
This study looked at how ready primary care doctors in the U.S. are to treat patients with opioid use disorder (OUD). Out of nearly 1,000 doctors surveyed, 80.7% felt comfortable screening for and diagnosing OUD, but only 36.9% were comfortable treating it with medications like buprenorphine. This is important because many doctors face barriers, like lack of training and fear of being overwhelmed with requests, which limits access to necessary treatment for those struggling with addiction. Who this helps: Patients with opioid use disorder and their families benefit from improved access to treatment.

Plain English
This research studied how proteins in a process called non-homologous end joining (NHEJ) help repair breaks in DNA. The scientists used a technique called cryo-EM to look at the structure of these proteins and found different forms of protein complexes that are crucial for DNA repair. They discovered that if certain parts of these protein complexes are changed or mutated, the repair process is harmed, which can lead to cell death or cancer. Who this helps: This helps patients at risk of genetic disorders or cancers due to faulty DNA repair mechanisms.

Plain English
This study looked at how higher organisms defend their genetic material from damage and foreign DNA, like viruses. The researchers found that different protective pathways in cells may actually use similar factors to strengthen their defensive responses. This is important because understanding these mechanisms could lead to better ways to protect against viral infections. Who this helps: This helps researchers and potentially patients with viral infections.

Plain English
This study looked at how certain proteins involved in DNA repair affect cells that lack a specific protein called ATM when exposed to a cancer treatment drug called camptothecin. Researchers found that when they removed another protein, DNA-PKcs, these ATM-deficient cells became less sensitive to the drug, meaning they could better survive the treatment. This is important because it reveals potential ways to improve cancer therapies by understanding how different DNA repair mechanisms work together. Who this helps: This helps cancer patients and doctors by providing insights into more effective treatment strategies.

Plain English
This study looked at how a protein called DNA-PK is activated by specific shapes of DNA known as hairpinned ends. Researchers found that while hairpinned DNA ends don't effectively activate DNA-PK for most of its usual jobs, they do trigger a part of the activation process that is crucial for another protein called Artemis to work properly. This is important because it helps us understand how DNA repair mechanisms function when DNA is damaged, particularly in some types of cells that struggle to fix breaks in their DNA. Who this helps: Patients with genetic disorders related to DNA repair, like certain cancers or syndromes.

Plain English
This study examined the data the U.S. Food and Drug Administration (FDA) needed to approve prescription opioid medications from 1997 to 2018. It found that of the 48 opioid drug applications reviewed, only 21 had trials lasting an average of about 84 days, and many trials excluded patients who might not tolerate the drugs well. This matters because it raises concerns about the safety and effectiveness of opioids for a broader patient population suffering from pain since many trials were conducted under very selective conditions. Who this helps: Patients with chronic pain and their doctors.

Plain English
This study looked at different ways that a specific deficiency (DNA-PKcs) affects cells in animal and lab models. Researchers found that mice lacking DNA-PKcs had more severe reactions than those with only its kinase activity disabled, particularly in how they responded to radiation—showing a significant increase in sensitivity. Understanding these differences is important because it can lead to better-targeted therapies for conditions involving DNA repair mechanisms. Who this helps: This benefits cancer patients and doctors working on improving treatment outcomes.

Plain English
This study looked at how well a new genetic testing method can detect large changes in genes that increase cancer risk, focusing on over 376,000 people tested from 2013 to 2017. Researchers found 3,461 significant gene changes, with 67.7% being harmful, and they showed that without this advanced testing method, around 9% of these important changes might have been missed, potentially affecting the care of 210 patients. This matters because identifying these genetic changes helps doctors make better decisions for managing patients' cancer risks. Who this helps: Patients at risk for hereditary cancers and their doctors.

Plain English
This study examined a protein called ALKBH1, which helps repair DNA and is found mainly in the mitochondria of cells. Researchers found that when they removed ALKBH1 from certain human cells, there was a rise in mitochondrial DNA and signs of mitochondrial dysfunction, such as slowed growth and reduced enzyme activity, indicating the protein plays an important role in keeping mitochondria healthy. Understanding ALKBH1's function helps highlight its significance in diseases related to mitochondrial problems. Who this helps: This research benefits patients with mitochondrial disorders and their doctors.

Plain English
This study looked at two proteins, XRCC4 and XLF, which play a key role in repairing broken DNA. Researchers found that when they changed specific parts of these proteins that respond to DNA damage, it affected how well XRCC4 and XLF could connect broken DNA strands—showing that they are important for this process. This matters because understanding how DNA repair works can help improve therapies for conditions caused by DNA damage, such as cancer. Who this helps: Patients with DNA repair disorders or cancer.

Plain English
This study looked at how cells deal with problems that stop DNA replication, which can happen when there are small damages to the DNA. Researchers found that an enzyme called DNA-PKcs is crucial for fixing these issues; specifically, it helps recruit a repair protein called XRCC1 to damaged areas to restart the replication process. They discovered that when DNA-PK is active, cells can restart 50% more of their stalled replication forks compared to when it's not functioning properly. Who this helps: This benefits cancer patients by improving understanding of DNA repair mechanisms, which can enhance treatment strategies.

Plain English
This study looked at how certain enzymes help repair DNA breaks that occur during a process called immunoglobulin class switch recombination (CSR), which is important for producing different types of antibodies in response to infections. Researchers found that when a key enzyme called DNA ligase IV is missing, two other enzymes, Ligase 1 and Ligase 3, step in to help repair the DNA breaks, ensuring the process can still occur, albeit less efficiently. Specifically, they found that removing Ligase 1 and Ligase 3 did not further decrease the repair effectiveness in the absence of Ligase 4, suggesting these enzymes work together to maintain CSR function. Who this helps: This research benefits doctors and scientists studying immune responses and could aid in developing treatments for patients with immune deficiencies.

Plain English
This study looked at how a protein called ATM interacts with another protein, DNA-PKcs, in human and mouse cells that are missing DNA-PKcs. The researchers found that restoring ATM in certain mouse cells significantly reduces a process called signal end joining from 85% down to 30%. This is important because understanding these interactions can improve strategies for treating genetic disorders and cancers related to DNA repair issues. Who this helps: This benefits researchers and healthcare providers working on genetic therapies and cancer treatments.

Plain English
This study investigated how a protein called ATM affects the repair of DNA breaks that occur during a specific process in immune cell development. The researchers found that ATM slows down the joining of DNA pieces by around 50%, helping to stabilize the complex involved in this repair process. Understanding how ATM works is important because it can lead to insights into DNA repair, which is crucial for preventing diseases like cancer. Who this helps: This helps patients at risk of immune disorders or cancers related to DNA repair issues.

Plain English
This study examined a protein called PAXX, which is involved in repairing DNA breaks in cells. The researchers found that cells without PAXX were still able to repair DNA normally, showing no issues when exposed to radiation or when testing a specific type of DNA repair called V(D)J recombination. This means that while PAXX is part of the DNA repair system, other proteins can compensate for its absence, especially another protein called XLF. Who this helps: This information benefits researchers and doctors working on treatments for diseases related to DNA damage, such as cancer.

Plain English
This study looked at how two proteins, XRCC4 and XLF, interact during the DNA repair process, especially when fixing breaks in DNA. Researchers found that while one version of XLF can still help repair DNA, the need for XRCC4 and XLF to work together varies across different cell types. Specifically, cells lacking both XRCC4 and another protein (ATM) showed a higher need for the XRCC4/XLF interaction, whereas the absence of the beginning protein PAXX did not affect this requirement as much. Who this helps: This research benefits scientists and researchers developing new treatments for genetic disorders related to DNA repair.

Plain English
This study looked at how different methods of stretching affect hamstring flexibility over a six-week period. Researchers had 34 young adults with tight hamstrings stretch for a total of 90 seconds, either by doing 9 repetitions of 10 seconds each or 3 repetitions of 30 seconds each. Both groups significantly improved their flexibility, increasing knee extension range by about 12 degrees, but there was no difference in effectiveness between the two methods. Who this helps: This helps patients with tight hamstrings, as they can choose either stretching method for the same benefits.

Plain English
This study looked at how a protein called DNA-PK helps repair DNA damage by adding chemical tags called phosphates to itself in specific areas. The researchers found that stopping this tagging process made cells much more sensitive to various types of DNA damage, making it harder for them to recover from issues like breaks or stress during DNA copying. This matters because understanding how DNA-PK works can help develop new treatments that enhance the effectiveness of therapies targeting cancer cells, which often rely on damaging DNA. Who this helps: This research benefits cancer patients and doctors looking for better treatment strategies.

Plain English
This study examined how two proteins, PLK1 and PP6, affect another protein called DNA-PKcs during cell division (mitosis). Researchers found that DNA-PKcs is modified at two specific sites during mitosis, with one modification depending on PLK1 and the other on DNA-PK itself, suggesting that these proteins play a unique role in mitosis separate from their function in repairing damaged DNA. This understanding could help improve cancer treatments by targeting these proteins more effectively. Who this helps: This benefits cancer patients by providing insights that could lead to better therapies.

Plain English
This study examined how nocturnal animals, like bats and owls, improve their night vision by changing the structure of their cell nuclei. They found that these animals position specific DNA regions at the center of their nuclei to enhance light focus on their eyes, but this makes their DNA more vulnerable to damage, as certain repairs can't happen in that dense area. Understanding this trade-off is important because it highlights how adaptations for survival, like improved vision, can also lead to risks for their DNA stability. Who this helps: This research benefits wildlife biologists and conservationists studying nocturnal animals.

Plain English
This study looked at two proteins, XRCC4 and XLF, that play a key role in repairing damaged DNA, specifically double strand breaks, which are serious harm to the DNA caused by things like radiation. The researchers found that XRCC4 and XLF can combine to form long structures that help protect and line up the ends of broken DNA, making it easier for the cell to repair the damage. This discovery is significant because it improves our understanding of how DNA repairs itself, which can impact approaches to cancer treatment and prevention. Who this helps: This helps patients, especially those at risk for cancer due to DNA repair issues.

Plain English
Researchers studied a patient with a rare condition called Severe Combined Immunodeficiency (SCID) caused by mutations in a gene known as PRKDC. They found that this patient not only had a severely impaired immune system with almost no T and B cells but also experienced serious neurological problems, including growth failure, severe brain abnormalities, and frequent seizures. This highlights that the PRKDC gene is crucial not only for immune system function but also for proper brain development in humans. Who this helps: This information is valuable for doctors and researchers treating patients with SCID and related neurological issues.

Plain English
This study focused on a protein called ALKBH1 and its role in two important processes in the body: fixing damaged DNA and switching types of antibodies. Researchers found that mice lacking ALKBH1 (called Alkbh1(-/-) mice) were born less frequently and mostly as males. They discovered that whether or not ALKBH1 was present had no impact on how well cells survived DNA damage or on the switching of antibodies, meaning ALKBH1 is not essential for these processes. Who this helps: This research benefits scientists studying DNA repair and immune responses.

Plain English
Researchers studied how two proteins, XRCC4 and XLF, work together in the process of repairing DNA. They found that if XRCC4 can't connect with XLF, it leads to problems with a specific type of DNA repair called coding end joining, which is important for creating immune system diversity, resulting in a 35% increase in repair deficits. However, this issue does not affect another type of repair called signal end joining. Who this helps: This benefits patients with immune deficiencies linked to DNA repair issues.